Hudson Executive Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-661,897
| Closed | -$39.8M | – | 9 |
|
|
2019
Q4 | $39.8M | Sell |
661,897
-148,468
| -18% | -$8.92M | 3.54% | 5 |
|
|
2019
Q3 | $45.8M | Sell |
810,365
-1,412
| -0.2% | -$79.9K | 3.47% | 5 |
|
|
2019
Q2 | $45.2M | Sell |
811,777
-159,223
| -16% | -$8.87M | 4.35% | 4 |
|
|
2019
Q1 | $49M | Hold |
971,000
| – | – | 4.55% | 3 |
|
|
2018
Q4 | $39.1M | Hold |
971,000
| – | – | 3.95% | 5 |
|
|
2018
Q3 | $67.3M | Hold |
971,000
| – | – | 5.44% | 4 |
|
|
2018
Q2 | $73.5M | Hold |
971,000
| – | – | 16.36% | 2 |
|
|
2018
Q1 | $51.2M | Hold |
971,000
| – | – | 15.09% | 2 |
|
|
2017
Q4 | $51.9M | Hold |
971,000
| – | – | 24.9% | 1 |
|
|
2017
Q3 | $57.9M | Buy |
971,000
+20,400
| +2% | +$1.22M | 29.13% | 1 |
|
|
2017
Q2 | $75M | Hold |
950,600
| – | – | 34.47% | 1 |
|
|
2017
Q1 | $78.8M | Hold |
950,600
| – | – | 21.62% | 1 |
|
|
2016
Q4 | $75.4M | Hold |
950,600
| – | – | 26.81% | 1 |
|
|
2016
Q3 | $66.5M | Hold |
950,600
| – | – | 11.81% | 1 |
|
|
2016
Q2 | $36.9M | Buy |
950,600
+528,600
| +125% | +$20.5M | 13.83% | 3 |
|
|
2016
Q1 | $17.1M | Buy |
+422,000
| New | +$17.1M | 3.94% | 7 |
|